Monoclonal antibodies and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8802383
APP PUB NO 20120295275A1
SERIAL NO

13472934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI PASTEUR LIMITEDTORONTO ON M2R 3T4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berinstein, Neil Toronto, CA 22 92
Gallichan, Scott Burington, CA 18 62
Lovitt, Corey Bolton, CA 10 33
Pedyczak, Artur Pickering, CA 12 56
Radvanyi, Laszlo Houston, US 14 59
Sandhu, Devender Satsangi Singh Thornhill, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 12, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00